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A b s t r A c t
Images are provided from a successful procedure of transcatheter aortic valve implan-
tation (TAVI) in an elderly patient with symptomatic low-flow, low-gradient critical 
aortic stenosis, and associated severe left ventricular dysfunction, who had a very high 
risk for surgery. 
An 83-year old lady with symptomatic low-flow, low-gradient critical aortic stenosis, 
severe left ventricular dysfunction and high-risk for surgery was successfully submitted 
to transcatheter aortic valve implantation (TAVI). About 2 years earlier the patient had 
sustained an acute myocardial infarction which was managed with primary percutaneous 
coronary intervention and stenting. However, she was left with severely compromised 
left ventricular function (ejection fraction 35%). She continued having symptoms of 
angina and shortness of breath, mostly attributed to known underlying critical aortic 
stenosis (aortic valve area 0.6 cm2; mean aortic gradient 34 mmHg). Due to worsening 
symptomatology over the preceding 6 months, the patient was evaluated for aortic 
valve replacement. She was though deemed a high-risk surgical candidate due to her 
age and underlying comorbidities (diabetes, hypertension, chronic pulmonary disease 
and poor left ventricular function). The logistic Euroscore was calculated at 32.51%. 
Thus, the patient was scheduled for TAVI, per the “Heart Team” recommendation, 
despite her severely compromised systolic ventricular function.
Balloon valvuloplasty was initially performed as seen in panel A. A first attempt to 
place a number 26 CoreValve (Medtronic Inc., Minneapolis, MN, USA) via the right 
femoral artery with use of an 18F delivery system (panel B, arrow) was unsuccessful 
due to downward displacement of the valve during the release process (panel C, arrow). 
The valve was recaptured and a second attempt was finally successful in implanting 
the valve at the correct position (panel D, arrow). Aortography demonstrated no 
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paravalvular regurgitation and the procedure was successfully 
completed with surgical closure of the femoral artery insertion 
site. Due to development and persistence of complete heart 
block after the procedure, in the setting of a pre-existing left 
bundle branch block, a permanent pacemaker was implanted 5 
days later. The patient’s course was complicated by worsening 
anemia in the setting of a pre-existing low hematocrit due to 
thalassemia trait treated with transfusion and also recurrent 
bouts of cellulitis in both arms treated with antibiotics, but 
she was finally discharged home in stable medical condition 
about 2 weeks later.
●●●
The availability of trancatheter aortic valve implantation 
(TAVI) represents a long-awaited and most important develop-
ment in the management of valvular heart disease for patients 
deemed to have a prohibitive or high surgical risk.1 Thus, an 
alternative to traditional surgical aortic valve replacement can 
now be offered to these patients.
However, very few studies have focused on outcomes of 
TAVI in patients with severe left ventricular dysfunction.2-5 
Conservative treatment of severe aortic stenosis associated 
with severely reduced left ventricular function carries a dismal 
prognosis. Thus, after the widespread use of and experience 
obtained from the TAVI procedure in patients with adequate 
left ventricular performance, the procedure has also been 
proposed and offered selectively to patients with severely 
compromised left ventricular function. Indeed, from the few 
data available, it appears that TAVI should not be withheld 
in selected patients with impaired left ventricular function.2-5
In the limited number of patient series available in the 
literature, a favorable periprocedural outcome, similar to 
our patient, has been reported, which was accompanied by a 
post-procedural recovery in left ventricular function translated 
into favorable long-term survival comparable to patients with 
normal or moderately reduced left ventricular function.2,3 
Thus, it has been suggested that severely compromised left 
ventricular function should not deter providers from offering 
TAVI to these patients with severe aortic stenosis who are at 
high risk for surgery.
Some investigators have suggested that the improvement 
in ejection fraction obtained after TAVI seems even better 
than that observed after surgical aortic valve replacement.4 
This may be possibly attributed to a superior hemodynamic 
performance of the transcatheter prosthesis affording a big-
ger effective orifice area and lower transvalvular gradient, or 
even better protection and improved recovery of myocardial 
function, by avoiding or minimizing ischemic and/or reperfu-
sion injury and inflammation conferred by cardioplegia and 
the surgical injury.
Of course, due to the severely compromised ventricular 
function, this subgroup of TAVI patients are expected to 
have a higher complication rate and higher 30-day (e.g. 10% 
vs 3%)4 or 1-year mortality rates (31% vs 13%),4 associated 
with a greater logistic Euroscore in these patients, an increased 
incidence of periprosthetic leaks (>2+/4), and higher rates of 
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congestive heart failure after TAVI.4,5 An additional significant 
predictor of mortality in this very high-risk subgroup of patients 
relates to the low-flow low-gradient aortic stenosis,5 as indeed 
was the case in our patient, whereby the mean aortic gradient 
was calculated at 34 mmHg, instead of a classical >40 mmHg 
gradient measured in critical aortic stenosis. Nevertheless, in 
view of the grave prognosis incurred by medical therapy in 
patients with critical aortic stenosis and severe left ventricu-
lar dysfunction, TAVI appears to be a feasible and effective 
procedure, and a viable option, even in this group of patients, 
as it leads to satisfactory procedural success rates and clinical 
improvement with even partial recovery of their left ventricu-
lar function.2-5 Although these results are encouraging, data 
from randomized trials are needed to determine whether this 
therapeutic strategy will also improve long-term survival rates 
in this subgroup of aortic stenosis patients.
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